Interactions Among CYP2C8, EPHX2, and CYP4A11 Variants and CYP Plasma Metabolite Levels in Ischemic Stroke

J Atheroscler Thromb. 2016 Nov 1;23(11):1286-1293. doi: 10.5551/jat.35279. Epub 2016 Apr 16.

Abstract

Aim: To better understand the relationship between the interactions among rs17110453, rs751141, and rs9333025 variants and plasma levels of cytochrome P450 (CYP) metabolites, i.e.,20-hydroxyeicosatetraenoic acid (20-HETE), epoxyeicosatrienoic acids (EETs), and dihydroxyeicosatrienoic acids (DiHETEs) in ischemia stroke (IS).

Methods: We measured plasma CYP metabolite levels in 218 acute IS cases and 126 controls, and a subset of samples were assessed to further understand the association between relevant variants and IS risk in our previous study. We assessed the associations between variant interactions and levels of 20-HETE, EETs, and DiHETEs as well as the associations between levels of 20-HETE, EETs, and DiHETEs and IS risk after adjusting for other potential confounders. Furthermore, the association between variant interactions and IS risk after adjusting for other covariates, including CYP metabolites levels, was evaluated.

Results: The interactions among variants rs17110453, rs751141, and rs9333025 were significantly associated with high 20-HETE, high DiHETEs, and low EETs after adjusting for the status of diabetes mellitus and hypertension. High 20-HETE, high DiHETEs, and low EETs were independent risk factors for IS after adjusting for hypertension, diabetes mellitus, and the interactions among rs17110453, rs751141, and rs9333025. Furthermore, the interactions among rs17110453, rs751141, and rs9333025 were significantly associated with a higher risk of IS after adjusting for CYP metabolites (OR=2.02, 95% CI: 1.28-5.27, P=0.007).

Conclusion: The association between the interactions among rs17110453, rs751141, and rs9333025 and IS risk in Chinese population may be partly but not exclusively mediated by plasma levels of 20-HETE, EETs, and DHETs. Further well-designed studies are warranted to replicate this finding.

MeSH terms

  • Aged
  • Biomarkers / analysis*
  • Brain Ischemia / blood
  • Brain Ischemia / genetics*
  • Brain Ischemia / pathology
  • Cytochrome P-450 CYP2C8 / genetics*
  • Cytochrome P-450 CYP4A / genetics*
  • Epoxide Hydrolases / genetics*
  • Female
  • Follow-Up Studies
  • Genetic Variation / genetics*
  • Genotype
  • Humans
  • Hydroxyeicosatetraenoic Acids / blood
  • Male
  • Prognosis
  • Stroke / blood
  • Stroke / genetics*
  • Stroke / pathology

Substances

  • Biomarkers
  • Hydroxyeicosatetraenoic Acids
  • 20-hydroxy-5,8,11,14-eicosatetraenoic acid
  • 5,15-dihydroxy-6,8,11,13-eicosatetraenoic acid
  • CYP2C8 protein, human
  • Cytochrome P-450 CYP2C8
  • CYP4A11 protein, human
  • Cytochrome P-450 CYP4A
  • Epoxide Hydrolases
  • EPHX2 protein, human